Fischer Medical Ventures’ Stock Up Today As Company Considers Stock Split

Mumbai, July 28- Fischer Medical Ventures Ltd (NSE: FISCHER) rose 2.1% in morning trade today, 28th July. At 2:50 p.m. the stock was up by 0.58% at Rs 951. The company will be holding a board meeting to consider a stock split.

Intraday Performance

As of 1:11 PM IST on July 28, Fischer Medical Ventures was trading at ₹956.50, a 1.23% increase. The stock opened at ₹950.00 and touched an intraday high of ₹967.95. VWAP stood at ₹961.17, indicating stable trading levels.

Market Capitalization

Fischer Medical Ventures has a total market capitalization of ₹6,228.99 crore, with a free float of ₹975.37 crore. The stock carries a face value of ₹10 and an annualised volatility of 26.94%. The board is meeting today to consider a stock split, intended to improve liquidity and expand retail participation.

Outlook

The stock split proposal has triggered buying interest, indicating market alignment with efforts to boost liquidity and retail participation. Future movement will depend on board approval and execution, which could broaden the investor base and support valuation at current earnings multiples.

About the Company

Fischer Medical Ventures Ltd is a Chennai-based MedTech company manufacturing advanced MRI systems and diagnostic technologies in India. With a facility at AMTZ, it develops cost-effective imaging solutions and point-of-care diagnostics aimed at improving accessibility and outcomes in global healthcare.

REF: https://nsearchives.nseindia.com/corporate/xbrl/PRIOR_INTIMATION_60565_1491213_23072025031517_WEB.xml

Disclaimer:  At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations